Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
12/27/2006 | CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
12/27/2006 | CN1886374A Process for preparing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives |
12/27/2006 | CN1886373A Method for preparing (s)-indoline-2-carboxylic acid and (s)-indoline-2-carboxylic acid methyl ester using hydrolytic enzyme |
12/27/2006 | CN1886372A 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
12/27/2006 | CN1886371A Processes for the preparation of a polymorph of fluvastatin sodium |
12/27/2006 | CN1886133A Indole compounds |
12/27/2006 | CN1886132A Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
12/27/2006 | CN1291989C Method for separating lycorine from plant extract |
12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
12/26/2006 | US7153977 Ligands and methods for preparing same |
12/26/2006 | US7153976 Contacting a mixture containing an azabicyclo[3.1.0]hexane compound and impurity at a first concentration with an alcohol; and recovering from mixture azabicyclo[3.1.0]hexane compound |
12/26/2006 | US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders |
12/26/2006 | US7153881 Compounds acting as melanocortin receptor ligands |
12/26/2006 | US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders |
12/21/2006 | WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/21/2006 | WO2006135804A1 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same |
12/21/2006 | WO2006135757A1 Crystalline forms of carvedilol and processes for their preparation |
12/21/2006 | WO2006135694A2 Uii-modulating compounds and their use |
12/21/2006 | WO2006135280A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
12/21/2006 | WO2006134989A1 Nitrogenated heterocyclic compound |
12/21/2006 | WO2006133885A1 Tricyclic fused indole derivatives and their use as aurora kinase inhibitors |
12/21/2006 | WO2006133823A1 Benzanilides with insecticidal activity |
12/21/2006 | WO2006133634A1 Tetrahydroindole derivatives and tetrahydroindazole derivatives, and use thereof |
12/21/2006 | WO2006091457A3 Ionic liquids derived from peracid anions |
12/21/2006 | WO2006031894A3 Methods of treating a disorder |
12/21/2006 | WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
12/21/2006 | WO2005092856A8 Tetrahydrocarbazoles and derivatives |
12/21/2006 | US20060287531 antiviral for HIV and AIDS; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-(4-fluoro-1H-indol-3-yl)-2-oxo-acetamide; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-oxo-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-acetamide |
12/21/2006 | US20060287396 4-aryl quinols and analogs thereof as therapeutic agents |
12/21/2006 | US20060287382 2-(1H-indolylsulfanyl)-aryl amine derivatives |
12/21/2006 | US20060287380 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
12/21/2006 | US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide, |
12/21/2006 | US20060287376 2-bromoaniline and 2-chloroaniline derivatives; used to make indole compounds |
12/21/2006 | US20060287370 Isoindolinone kinase inhibitors |
12/21/2006 | US20060287362 Organic compounds |
12/21/2006 | US20060287336 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
12/21/2006 | US20060287321 Novel Lactam Derivatives |
12/21/2006 | US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
12/21/2006 | US20060287280 N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; zinc metallopeptidase inhibitors; promoting faster regeneration of bone mass after bone fractures, implantation of orthopedic and dental prostheses; osteogenesis stimulant; control phosphate metabolism |
12/21/2006 | US20060286483 Cyanine compounds, optical recording materials and optical recording media |
12/21/2006 | CA2612324A1 N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents |
12/21/2006 | CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/20/2006 | EP1734041A2 Platelet ADP receptor inhibitors |
12/20/2006 | EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders |
12/20/2006 | EP1733726A1 Pharmaceutically active isoindoline derivatives |
12/20/2006 | EP1732930A2 2,4,6-phenylsubstituted cyclic ketoenoles |
12/20/2006 | EP1732892A1 Tetrahydrocarbazoles and derivatives |
12/20/2006 | EP1732891A1 Resistance-repellent retroviral protease inhibitors |
12/20/2006 | EP1732890A1 Crystalline polymorph of a bazedoxifene acetate |
12/20/2006 | EP1732889A1 Crystalline polymorph of bazedoxifene acetate |
12/20/2006 | EP1732888A1 Bazedoxifene ascorbate as selective estrogen receptor modulator |
12/20/2006 | EP1732887A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
12/20/2006 | EP1732884A1 Sulphonamide derivatives |
12/20/2006 | EP1732865A1 Fluoridation method |
12/20/2006 | EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
12/20/2006 | EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
12/20/2006 | EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
12/20/2006 | EP1276720B1 2-acyl indol derivatives and their use as anti-tumour agents |
12/20/2006 | CN1882575A Substituted pyrrole-indoles as inhibitors of PAI-1 |
12/20/2006 | CN1882539A Processes for the preparation of N-substituted phthalimides |
12/20/2006 | CN1882538A Substituted sulfonamide-indole-2-carboxylic acid derivatives as PAI-1 inhibitors |
12/20/2006 | CN1882537A Substituted indole acid derivatives and their use as PAI-1 inhibitors |
12/20/2006 | CN1882527A Biphenyloxy-acids |
12/20/2006 | CN1882333A Indole antiviral compositions and methods |
12/20/2006 | CN1882323A Substituted benzofuran oximes |
12/20/2006 | CN1880316A Method for producing folic acid antagonist and its intermediate |
12/20/2006 | CN1880305A Production method of n-(cyclohixylthio) phthalimide |
12/20/2006 | CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes |
12/20/2006 | CN1880293A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
12/20/2006 | CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor |
12/20/2006 | CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
12/20/2006 | CN1290832C 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
12/14/2006 | WO2006133326A1 Inhibitors of hcv replication |
12/14/2006 | WO2006132432A1 Therapeutic agent for neurogenic pain |
12/14/2006 | WO2006131828A1 A process for the preparation of perindopril |
12/14/2006 | WO2006131484A1 Indole derivatives having antitumor activity |
12/14/2006 | WO2006131482A1 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents |
12/14/2006 | WO2006131465A1 Reversibly thermochromic compositions |
12/14/2006 | WO2006131186A1 Oxindoles as kinase inhibitors |
12/14/2006 | WO2006082409A3 Tricyclic cytoprotective compounds |
12/14/2006 | WO2006078274A3 Beta-peptides |
12/14/2006 | US20060282038 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
12/14/2006 | US20060281811 Synthesis of taxol enhancers |
12/14/2006 | US20060281805 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection |
12/14/2006 | US20060281804 N-Benzyl-2,3,4,9-tetrahydrocarbazole-1-amine hydrochloride salt, for the treatment of human papillomaviruses infection, genital warts, or cervical dysplasia |
12/14/2006 | US20060281796 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/14/2006 | US20060281629 Catalyzing the oxidation, carbonylation, nitration, sulfonation reaction; catalyst selectivity; produce terephthalic acid from p-xylene or from p-toluic acid; produce pyromellitic acid from durene |
12/14/2006 | CA2611401A1 Oxindoles as kinase inhibitors |
12/14/2006 | CA2607337A1 Indole derivatives having antitumor activity |
12/14/2006 | CA2607184A1 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents |
12/14/2006 | CA2601202A1 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them |
12/13/2006 | EP1731506A1 5-hydroxyindole-3-carboxylates derivatives and their use |
12/13/2006 | EP1731505A1 Alkoxyphenylpropanoic acid derivatives |
12/13/2006 | EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
12/13/2006 | EP1730165A1 Inhibitors of hepatitis c virus ns3 protease |
12/13/2006 | EP1730142A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |